Management Changes
Star Health Announces Board-Level Changes Following Share Transmission of Late Rakesh Jhunjhunwala
NSE
STARHEALTH
BSE
543412
Star Health & Allied Insurance Company Limited has announced multiple board-level changes, including the retirement of two Independent Directors, transmission of Late Rakesh Jhunjhunwala’s shareholding, resignation of the existing nominee director, and appointment of Utpal Sheth as Nominee Director representing promoter entity Sitara Partners LLP.
PRICE-SENSITIVE TRIGGER
Event: Board Meeting Outcome
Type: Management Changes / Corporate Governance Update
Impact: Neutral
Immediate Effect: The company has undertaken board restructuring following the transmission of Late Rakesh Jhunjhunwala’s equity shares and changes in board representation while maintaining governance continuity.
Highlight:
- Board governance restructuring following promoter share transmission.
What Happened ?
Star Health’s Board approved a series of governance-related changes during its meeting held on June 26, 2026.
Two Independent Directors—Rajeev Krishnamuralilal Agarwal and Rajni Sekhri Sibal—will retire upon completion of their five-year tenure effective July 15, 2026.
The company also completed the transmission of 8,28,82,958 equity shares previously held by Late Rakesh Jhunjhunwala pursuant to the Probate issued by the Bombay High Court.
Consequent to this transmission, Utpal Hemendra Sheth resigned as Nominee Director representing the Estate of Late Rakesh Jhunjhunwala and was simultaneously appointed as Additional Non-Executive Director representing promoter entity Sitara Partners LLP, subject to shareholder approval.
Key Details
Key Board Decisions:
- Independent Director Rajeev Krishnamuralilal Agarwal will retire on July 15, 2026 after completion of his statutory tenure.
- Independent Director Rajni Sekhri Sibal will also retire on July 15, 2026.
- Transmission of 8,28,82,958 equity shares held by Late Rakesh Jhunjhunwala has been completed pursuant to Probate issued by the Bombay High Court.
- Utpal Hemendra Sheth resigned as Nominee Director representing the Estate of Late Rakesh Jhunjhunwala with effect from June 26, 2026.
- The resignation followed withdrawal of nomination after completion of share transmission.
- Utpal Sheth has been appointed as Additional Director under the Non-Executive category representing Sitara Partners LLP, the promoter of the company.
- The appointment has received IRDAI approval dated April 6, 2026 and remains subject to shareholder approval.
- Utpal Sheth has over 35 years of capital market experience and has previously served as CEO and Senior Partner at Rare Enterprises.
Note:
- The filing primarily relates to board composition and governance changes. No operational, business or financial decisions were announced.
Risk Analysis
Summary:
- The disclosure represents routine governance restructuring following promoter share transmission and completion of Independent Directors’ tenure.
Key Risks:
- Appointment of the new nominee director remains subject to shareholder approval.
- Retirement of experienced Independent Directors requires continued board succession planning.
- No impact on the company’s insurance operations has been indicated.
Worst Case:
- Any delay in obtaining shareholder approval could temporarily postpone formal board representation for the promoter nominee.
Risk Level: Low
Company Commentary
- The Board recorded its appreciation for the contributions made by the retiring Independent Directors.
- Transmission of Late Rakesh Jhunjhunwala’s shareholding has been completed in accordance with the Probate issued by the Bombay High Court.
- Utpal Sheth’s appointment has been approved by IRDAI and is subject to shareholder approval.
- The company stated that the information has also been made available on its website in accordance with regulatory requirements.
Official Exchange Filing: Star Health & Allied Insurance Company Limited
